POINT Biopharma
PNT
$12.50
Share price
0.00%
Change (1 day)
84.37%
Change (1 year)
Categories
POINT Biopharma (PNT) - Cash on Hand
Cash on Hand as of September 2023 : $0.33 B
According to POINT Biopharma's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
POINT Biopharma - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.52 B | 119.92% |
| 2021-12-31 | $0.23 B | 2164.36% |
| 2020-12-31 | $10.54 M |